GRIFOLS, S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.545 EUR | +0.69% |
|
-2.89% | -37.96% |
| Jun. 17 | Sector Update: Health Care Stocks Retreat Late Afternoon | MT |
| Jun. 17 | Grifols' Biotest Gets FDA Approval for Yimmugo | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 5.94B | ||||||
| 92.38B | ||||||
| 37.9B | ||||||
| 33.73B | ||||||
| 27.98B | ||||||
| 15.86B |
